Drawing for STARNIIVA

USPTO serial 79048832

STARNIIVA

Reviewed by CopyMark Law Group

Reg. 3485342Status 404
Filing date
Status date
Registration date
Aug 12, 2008
Examiner
CHARLON, BARNEY
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with STARNIIVA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for inflammatory and immunological diseases and disorders, reproductive health diseases and disorders, neurological diseases and disorders, oncological diseases and disorders, cardiovascular diseases and disorders, pulmonary diseases and disorders, endocrinological diseases and disorders, growth hormone diseases and disorders, genetic diseases and disorders, metabolic diseases and disorders, diabetic diseases and disordersSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 6, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Jul 6, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 20, 2016INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jan 29, 2016INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jan 29, 2016INPCINVALIDATION PROCESSED—
Nov 13, 2015INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 13, 2015C71TCANCELLED SECTION 71—
Jan 1, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 8, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 8, 2008FIMPFINAL DISPOSITION PROCESSED—
Nov 13, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 12, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 27, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 7, 2008NPUBNOTICE OF PUBLICATION—
Apr 22, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 16, 2008ALIEASSIGNED TO LIE—
Apr 11, 2008RFNTREFUSAL PROCESSED BY IB—
Apr 10, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 9, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 7, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 7, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 7, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 18, 2008RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 18, 2008RFRRREFUSAL PROCESSED BY MPU—
Mar 18, 2008RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 17, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 17, 2008DOCKASSIGNED TO EXAMINER—
Feb 15, 2008NWAPNEW APPLICATION ENTERED—
Feb 14, 2008REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance